← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2007Last known activity
Apr 13, 2024
Timeline
1990s
- Jun 1, 1997
Therapeutics, Inc.— Founded
Drugs by trial phase (28 distinct, 45 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT06363461CollaboratorPhase 2Apr 13, 2024
- NCT05760248CollaboratorPhase 2May 4, 2023
- NCT05789056Study directorPhase 2/Phase 3Mar 14, 2023
- NCT05802173CollaboratorPhase 2Mar 6, 2023
- NCT05525468CollaboratorPhase 1Oct 15, 2022
- NCT05521438Study directorPhase 2/Phase 3Jun 23, 2022
- NCT05348200CollaboratorPhase 2Apr 22, 2022
- NCT05363449Lead sponsorPhase 1Feb 17, 2022
- NCT05244980CollaboratorPhase 1Feb 1, 2022
- NCT04913519Study directorPhase 1Apr 27, 2021
- NCT04913519CollaboratorPhase 1Apr 27, 2021
- NCT04535531CollaboratorPhase 3Sep 1, 2020
- NCT04159610CollaboratorPhase 2Feb 1, 2020
- NCT04243486Study directorPhase 2Jan 2, 2020
- NCT04243486Lead sponsorPhase 2Jan 2, 2020
Details
- Founded
- San Diego, CA, US Jun 1, 1997
- Last known activity
- Apr 13, 2024
Notes
CRO